wn/den4-3'delta30
Vaccineexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2005 (NCT00094718)
Timeline
2000s
- Jan 1, 2005
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Dengue virusImmunity, active
Dengue virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- wn/den4-3'delta30
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02186626 | Phase 1 | Feb 1, 2014 | Johns Hopkins University, National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT00537147 | Phase 1 | Mar 1, 2008 | Johns Hopkins University, National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT00094718 | Phase 1 | Feb 1, 2005 | Johns Hopkins University, National Institute of Allergy and Infectious Diseases (NIAID) |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Johns Hopkins University | Academic/Hospital | 3 | 0 | 1 | 2005 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 3 | 3 | 1 | 2005 |
2 organizations
Page 1 / 1